Therapeutic Update in Neonatal Opioid Withdrawal Syndrome: Comparative Effectiveness of Pharmacological Treatments

José Miguel Pérez-Jiménez1,2,3,4, Marta Periañez Langa2, Manuel Coheña Jimenez1,5

  • 1Institute of Biomedicine of Seville (IBiS) Seville Spain.

Health Science Reports
|April 20, 2026
PubMed

Insights

Neonatal opioid withdrawal syndrome (NOWS) management requires updated therapeutic approaches. Clonidine and buprenorphine are safer alternatives to morphine, and nursing-led care improves outcomes for infants and mothers.

Area of Science:

  • Neonatal care
  • Pharmacology
  • Evidence-based practice

Background:

  • Neonatal opioid withdrawal syndrome (NOWS) is increasing due to maternal opioid use.
  • Current therapeutic strategies for NOWS lack precise definition, impacting infant and maternal health.
  • There is a critical need to update clinical and therapeutic approaches for NOWS.

Purpose of the Study:

  • To update the therapeutic approach for neonates with NOWS.
  • To clarify the role of nursing in managing NOWS.
  • To provide evidence-based recommendations for opioid-exposed newborns.

Main Methods:

  • Systematic review conducted following PRISMA guidelines and the Cochrane Handbook.
  • Searched Scopus, Dialnet, Cinahl, and PubMed databases.
  • Included studies focused on therapeutic updates and nursing roles in NOWS; excluded case studies, non-opioid substances, and guidelines.

Main Results:

  • Analysis of 28 publications highlighted the need for updated diagnostic scales and treatments for NOWS.
  • Clonidine and buprenorphine showed better safety and shorter treatment durations than morphine for NOWS symptoms.
  • The ESC model with non-pharmacological interventions outperformed traditional Finnegan scoring.

Conclusions:

  • Clonidine and buprenorphine offer improved safety and efficacy over morphine in NOWS management.
  • The ESC model and non-pharmacological interventions significantly reduce pharmacotherapy, hospital stay, and costs.
  • Nursing-led holistic care is crucial for comprehensive NOWS management, enhancing breastfeeding and parental involvement.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...